Vivo Capital »

Abivax SA F shares owned by Vivo Capital

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $31M 359k 84.90

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Cidara Therapeutics Common (CDTX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Cogent Biosciences Common (COGT)
Sinovac Biotech SHS
Oric Pharmaceuticals Common (ORIC)
Geron Corp Common (GERN)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Bright Minds Biosciences Common (DRUG)
Tourmaline Bio Common (TRML)

View all positions for Vivo Capital

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F